(1)
Rafeh Naqash, A. .; Yang, L. V. .; Sanderlin, E. J. .; Atwell, D. C. .; Walker, P. R. . Interleukin-6 As One of the Potential Mediators of Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Blockade: Evidence from a Case Report. AO 2018, 57, 705-708.